Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Lambert

Showing results (131-140 of 167) with videos related to

Pageof 17
Sort By:
Psychiatry Research|March 15, 2026
Costs and cost-effectiveness of stepped, evidence-based and integrated care for common and persistent severe mental illness: Results of the RECOVER trialAnja Zimmermann, Leon Kreis, Clara Janßen, et al.
The Journal of Nervous and Mental Disease|September 27, 2014
Patterns and correlates of expressed emotion, perceived criticism, and rearing style in first admitted early-onset schizophrenia spectrum disordersGeorg G von Polier, Heiner Meng, Martin Lambert, et al.
Early Intervention in Psychiatry|March 27, 2015
Clinical high risk for psychosis: gender differences in symptoms and social functioningLiz Rietschel, Martin Lambert, Anne Karow, et al.
Schizophrenia Bulletin|August 24, 2011
Rationale and baseline characteristics of PREVENT: a second-generation intervention trial in subjects at-risk (prodromal) of developing first-episode psychosis evaluating cognitive behavior therapy, aripiprazole, and placebo for the prevention of psychosisAndreas Bechdolf, Hendrik Müller, Hartmut Stützer, et al.
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|January 10, 2019
[Innovative care models for people with schizophrenia]Martin Lambert, Vivien Kraft, Anja Rohenkohl, et al.
The Journal of Clinical Psychiatry|September 5, 2014
Effectiveness of integrated care including therapeutic assertive community treatment in severe schizophrenia spectrum and bipolar I disorders: the 24-month follow-up ACCESS II studyDaniel Schöttle, Benno G Schimmelmann, Anne Karow, et al.
European Archives of Psychiatry and Clinical Neuroscience|September 14, 2012
Rationale and content of psychenet: the Hamburg Network for Mental HealthMartin Härter, Maren Kentgens, Andreas Brandes, et al.
Schizophrenia Research|October 19, 2016
Prevalence of metabolic syndrome in female and male patients at risk of psychosisJoachim Cordes, Andreas Bechdolf, Christina Engelke, et al.
International Journal of Bipolar Disorders|July 2, 2020
Improving early recognition and intervention in people at increased risk for the development of bipolar disorder: study protocol of a prospective-longitudinal, naturalistic cohort study (Early-BipoLife)Andrea Pfennig, Karolina Leopold, Julia Martini, et al.
International Journal of Bipolar Disorders|February 18, 2025
Quality of life in persons at risk for bipolar disorder: a two year prospective-longitudinal observational cohort study (BipoLife)Johanna Glaus, Anne Karow, Martin Lambert, et al.
Pageof 17

Showing results (131-140 of 167) with videos related to

Sort By:
Pageof 17
Psychiatry Research|March 15, 2026
Costs and cost-effectiveness of stepped, evidence-based and integrated care for common and persistent severe mental illness: Results of the RECOVER trialAnja Zimmermann, Leon Kreis, Clara Janßen, et al.
The Journal of Nervous and Mental Disease|September 27, 2014
Patterns and correlates of expressed emotion, perceived criticism, and rearing style in first admitted early-onset schizophrenia spectrum disordersGeorg G von Polier, Heiner Meng, Martin Lambert, et al.
Early Intervention in Psychiatry|March 27, 2015
Clinical high risk for psychosis: gender differences in symptoms and social functioningLiz Rietschel, Martin Lambert, Anne Karow, et al.
Schizophrenia Bulletin|August 24, 2011
Rationale and baseline characteristics of PREVENT: a second-generation intervention trial in subjects at-risk (prodromal) of developing first-episode psychosis evaluating cognitive behavior therapy, aripiprazole, and placebo for the prevention of psychosisAndreas Bechdolf, Hendrik Müller, Hartmut Stützer, et al.
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|January 10, 2019
[Innovative care models for people with schizophrenia]Martin Lambert, Vivien Kraft, Anja Rohenkohl, et al.
The Journal of Clinical Psychiatry|September 5, 2014
Effectiveness of integrated care including therapeutic assertive community treatment in severe schizophrenia spectrum and bipolar I disorders: the 24-month follow-up ACCESS II studyDaniel Schöttle, Benno G Schimmelmann, Anne Karow, et al.
European Archives of Psychiatry and Clinical Neuroscience|September 14, 2012
Rationale and content of psychenet: the Hamburg Network for Mental HealthMartin Härter, Maren Kentgens, Andreas Brandes, et al.
Schizophrenia Research|October 19, 2016
Prevalence of metabolic syndrome in female and male patients at risk of psychosisJoachim Cordes, Andreas Bechdolf, Christina Engelke, et al.
International Journal of Bipolar Disorders|July 2, 2020
Improving early recognition and intervention in people at increased risk for the development of bipolar disorder: study protocol of a prospective-longitudinal, naturalistic cohort study (Early-BipoLife)Andrea Pfennig, Karolina Leopold, Julia Martini, et al.
International Journal of Bipolar Disorders|February 18, 2025
Quality of life in persons at risk for bipolar disorder: a two year prospective-longitudinal observational cohort study (BipoLife)Johanna Glaus, Anne Karow, Martin Lambert, et al.
Pageof 17